Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
ilaria.delgiudice@uniroma1.it
Ilaria Del Giudice
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
ilaria.delgiudice@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy
BRITISH JOURNAL OF HAEMATOLOGY
2019
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia
BRITISH JOURNAL OF CANCER
2019
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
FRONTIERS IN ONCOLOGY
2019
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network
HEMATOLOGICAL ONCOLOGY
2019
TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IBRUTINIB TREATMENT.
HemaSphere
2019
IBRUTINIB TREATMENT DOESN’T INDUCE TP53 CLONAL EVOLUTION IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Haematologica 2019; 104(s2):1
2019
Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders
LEUKEMIA & LYMPHOMA
2018
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients
ANNALS OF ONCOLOGY
2018
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile
LEUKEMIA
2018
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
BRITISH JOURNAL OF HAEMATOLOGY
2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib
BRITISH JOURNAL OF HAEMATOLOGY
2018
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
2018
TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IMMUNOCHEMOTHERAPY AND IBRUTINIB.
Haematologica, 2018; 103 (s3): s27
2018
Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma
BRITISH JOURNAL OF HAEMATOLOGY
2017
Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients
ONCOTARGET
2017
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network.
LEUKEMIA & LYMPHOMA
2016
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin
BRITISH JOURNAL OF HAEMATOLOGY
2016
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments
BRITISH JOURNAL OF HAEMATOLOGY
2016
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
ONCOTARGET
2016
Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia
BRITISH JOURNAL OF HAEMATOLOGY
2016
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Multicentric retrospective-prospective observational study on the clinical application of the molecular profile (somatic mutations of IGHV and TP53 genes) to guide the therapeutic choices in the real-life for patients affected by chronic lymphocytic...
Monitoraggio non invasivo della leucemia linfatica cronica trattata con approcci 'chemo-free' mediante next-generation sequencing/droplet digital PCR sul DNA tumorale plasmatico circolante (ctDNA).
MUTAZIONI CLONALI E SUBCLONALI DEI GENI TP53, BTK e PLCg2 NELLA LEUCEMIA LINFATICA CRONICA PRE- E POST-TERAPIA. USO DELLE TECNICHE DI NEXT-GENERATION SEQUENCING PER LO STUDIO DELL'EVOLUZIONE CLONALE DELLA MALATTIA E DEI MARCATORI ASSOCIATI ALLA REFR...
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma